OTCM
WILYY
Market cap7.87bUSD
Jun 18, Last price
19.25USD
1D
0.00%
1Q
43.12%
Name
Demant A/S
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Demant A/S is a leading global enterprise specializing in the fields of hearing healthcare and audio technology. The company's primary focus is on the research, production, and sale of advanced solutions and devices aimed at enhancing individuals' hearing abilities across Europe, North America, the Pacific region, Asia, and other international territories. Its operations are strategically divided into two core segments: Hearing Healthcare and Communications. The Hearing Healthcare division provides a comprehensive suite of offerings, including hearing implants, assistive listening devices, audiological care services, and diagnostic equipment. Conversely, the Communications segment is dedicated to furnishing high-quality headsets for collaborative professional environments and the competitive gaming market, distributed under its EPOS brand. Originally established in 1904, the organization was previously known as William Demant Holding A/S, officially adopting its current name, Demant A/S, in March 2019. The corporate headquarters for Demant A/S are located in Smørum, Denmark.
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||